Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: CA Cancer J Clin. 2012 May 10;62(5):309–335. doi: 10.3322/caac.20132

FIGURE 6.

FIGURE 6

Mechanisms Underlying the Antitumor Activity of Monoclonal Antibody-Based Immunotherapy. TA indicates tumor antigens; FcR, Fc receptor; NK, natural killer; DC, dendritic cell; VEGF, vascular endothelial growth factor.